Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$56.69 USD
+0.73 (1.30%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $56.66 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC11/12/24 |
---|---|
Current Quarter | -0.91 |
EPS Last Quarter | -0.94 |
Last EPS Surprise | -9.30% |
ABR | 1.15 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.72 |
Next Year | -3.86 |
EPS (TTM) | -3.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.87M | 1.25M | 1.72M | 16.91M |
# of Estimates | 2 | 2 | 6 | 7 |
High Estimate | 1.10M | 1.87M | 4.01M | 57.02M |
Low Estimate | 0.63M | 0.63M | 1.00M | 3.00M |
Year ago Sales | 0.35M | 0.00M | 4.01M | 1.72M |
Year over Year Growth Est. | 147.14% | NA | -57.06% | 881.20% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.91 | -0.93 | -3.72 | -3.86 |
# of Estimates | 8 | 8 | 9 | 7 |
Most Recent Consensus | -0.88 | -0.91 | -3.91 | -3.89 |
High Estimate | -0.85 | -0.84 | -3.47 | -2.85 |
Low Estimate | -0.96 | -1.07 | -3.91 | -4.38 |
Year ago EPS | -1.01 | -0.90 | -3.69 | -3.72 |
Year over Year Growth Est. | 9.90% | -3.33% | -0.81% | -3.93% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.91 | -0.93 | -3.72 | -3.86 |
7 Days Ago | -0.91 | -0.93 | -3.72 | -3.86 |
30 Days Ago | -0.91 | -0.93 | -3.72 | -3.86 |
60 Days Ago | -0.91 | -0.93 | -3.72 | -3.86 |
90 Days Ago | -0.88 | -0.90 | -3.54 | -3.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.91 | -0.93 | -3.72 | -3.86 |
Zacks Consensus Estimate | -0.91 | -0.93 | -3.72 | -3.86 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.94 | -0.93 | -0.90 | -1.01 | NA |
Estimate | -0.86 | -0.84 | -0.89 | -0.89 | NA |
Difference | -0.08 | -0.09 | -0.01 | -0.12 | -0.08 |
Surprise | -9.30% | -10.71% | -1.12% | -13.48% | -8.65% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more